Validation of novel blood-based biomarkers specific to PSP pathology

Maura Malpetti, University of Cambridge


Abstract:

PSP is a severe brain disease that causes problems with balance, eye movements, speech and thinking, and for which there are no effective treatments. One major barrier to progress is the lack of blood tests that can detect the early build up of abnormal tau protein in the brain, or predict how quickly someone’s PSP will progress.

Our team has developed a highly sensitive “single molecule” method (SiMPull), that can detect and measure tiny clumps of proteins, one by one, in brain tissue and blood, and also adapted a commercial instrument (Simoa) to detect low levels of these clumps. In a pilot study, we have already shown that tau clumps look different in PSP compared with other conditions, like Alzheimer’s, and that combining tau measures with markers of brain inflammation improves diagnosis. Here, we will apply and validate these tests in blood of 150 people with PSP who attend our specialist clinic, where they have undergone detailed clinical assessments and brain scans over time. From the same participants, we also have brain tissue donated after death, allowing us to compare changes in blood directly with changes in the brain.

We will first refine and standardise our blood tests for tau, related proteins and inflammation. We will then ask whether the patterns we see in blood reflect the amount and distribution of abnormal tau in the brain, and whether they can help predict how quickly a person’s PSP will progress. Finally, we design practical blood test panels that could be used in future clinical trials and, in time, routine care.

If successful, this work will provide new blood tests that can (i) detect PSP type tau changes earlier, (ii) help distinguish PSP from related conditions, and (iii) identify people who are likely to progress more quickly and who might benefit most from new treatments. The study is supported by people living with PSP, with a dedicated patient group providing regular input into priorities, design and communication.